MinaRBrunnerHI. Pediatric lupus—are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?Rheum Dis Clin North Am2010; 36: 53–80.
2.
SibbittWLJrBrandtJRJohnsonCR. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol2002; 29: 1536–1542.
3.
WyckoffPM.MillerLCTuckerLBSchallerJG. Neuropsychological assessment of children and adolescents with systemic lupus erythematosus. Lupus1995; 4: 217–220.
4.
BrunnerHIKlein-GitelmanMSZelkoF. Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupus erythematosus. Arthritis Care Res2013; 65: 372–381.
5.
American College of Rheumatology. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum1999; 42: 599–608.
6.
RossGSZelkoFKlein-GitelmanM. A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus. Arthritis Care Res2010; 62: 1029–1033.
7.
MoorthyLNPetersonMOnelKBHarrisonMJLehmanTJ. Quality of life in children with systemic lupus erythematosus. Curr Rheumatol Rep2005; 7: 447–452.
8.
DickersonMSCalhousSLCrowellEW. Clinical validity and interpretation of the GDS in ADHD assessments. Child Neuropsychol2001; 7: 32–41.
9.
MoorthyLNPetersonMGBaratelliM. Multicenter validation of a new quality of life measure in pediatric lupus. Arthritis Rheum2007; 57: 1165–1173.
10.
GordonMMcClureDFAylwardGP. The Gordon Diagnostic System (GDS) Instruction Manuel & Interpretive Guide, 3rd edn. DeWitt, NY: GSI Publications, 1996.